The Potential Value Of The Neutral Comet Assay And Gamma H2ax Foci Assay In Assessing The Radiosensitivity Of Carbon Beam In Human Tumor Cell Lines

Background. Carbon ions (C-12(6+)) are high linear energy transfer (LET) radiation characterized by higher relative biological effectiveness than low LET radiation. The assessment of tumour radiosensitivity would be particularly useful in optimizing the radiation dose during radiotherapy. The aim of the current study was to evaluate the potential value of the neutral comet assay and gamma H2AX foci assay in assessing C-12(6+) radiosensitivity of tumour cells.Materials and methods. The doses of C-12(6+) and X-rays used in the present study were 2 and 4 Gy. The survival fraction, DNA double-strand breaks (DSB) and repair kinetics of DSB were assayed with clonogenic survival, neutral comet assay and gamma H2AX foci assay in human cervical carcinoma HeLa cells, hepatoma HepG2 cells, and mucoepidermoid carcinoma MEC-1 cells at the time points of 0.5, 4, 16 and 24 h after C-12(6+) and X-rays irradiation.Results. The survival fraction for 12C6+ irradiation was much more inhibited than for X-rays (p < 0.05) in all three tumour cell lines tested. Substantial amounts of residual damage, assessed by the neutral comet assay, were present after irradiation (p < 0.05). The highest residual damage was observed at 0.5 or 4 h, both for C-12(6+) and X-ray irradiation. However, the residual damage in HeLa and MEC-1 cells was higher for C-12(6+) than X-rays (p < 0.05). The strongest induction of gamma H2AX foci was observed after 30 min, for all three tumour cell lines (p < 0.01). The franction of gamma H2AX foci persisted for at least 24 h after C-12(6+) irradiation; in HeLa cells and MEC-1 was higher than after X-ray irradiation (p < 0.05). The correlation coefficients between the clonogenic survival, neutral comet assay and gamma H2AX foci assay were not statistically significant, except for some tumour cells at individual irradiation doses and types.Conclusions. Our study demonstrated that the neutral comet assay and gamma-H2AX foci assay could be used to assess the radiosensitivity of C-12(6+) in human tumour cells.